NO179949C - Analogifremgangsmåte for fremstilling av medisinsk virksomme 1-karboksyalkylkinoksalin-2,3 (1H,4H) -dionforbindelser og farmasöytisk godtagbare salter derav - Google Patents

Analogifremgangsmåte for fremstilling av medisinsk virksomme 1-karboksyalkylkinoksalin-2,3 (1H,4H) -dionforbindelser og farmasöytisk godtagbare salter derav

Info

Publication number: NO179949C
Authority: NO; Norway
Prior art keywords: carboxyalkylquinoxaline; preparation; pharmaceutically acceptable; acceptable salts; dione compounds
Prior art date: 1990-03-16

Application number

NO923586A

Other languages

English (en)

Norwegian (no)

Other versions

NO923586D0 (no

NO179949B (no

NO923586L (no

Inventor

Anker Steen Joergensen

Carsten Enggaard Stidsen

Peter Faarup

Frederik Christian Groenvald

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-16

Filing date

1992-09-15

Publication date

1997-01-15

1992-09-15 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1992-09-15 Publication of NO923586D0 publication Critical patent/NO923586D0/no

1992-09-15 Publication of NO923586L publication Critical patent/NO923586L/no

1996-10-07 Publication of NO179949B publication Critical patent/NO179949B/no

1997-01-15 Publication of NO179949C publication Critical patent/NO179949C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO923586A 1990-03-16 1992-09-15 Analogifremgangsmåte for fremstilling av medisinsk virksomme 1-karboksyalkylkinoksalin-2,3 (1H,4H) -dionforbindelser og farmasöytisk godtagbare salter derav NO179949C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK069790A DK69790D0 (da)	1990-03-16	1990-03-16	Heterocykliske forbindelser, deres fremstilling af anvendelse
PCT/DK1991/000078 WO1991013878A1 (en)	1990-03-16	1991-03-15	Quinoxaline compounds and their preparation and use

Publications (4)

Publication Number	Publication Date
NO923586D0 NO923586D0 (no)	1992-09-15
NO923586L NO923586L (no)	1992-09-15
NO179949B NO179949B (no)	1996-10-07
NO179949C true NO179949C (no)	1997-01-15

Family

ID=8096500

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO923586A NO179949C (no)	1990-03-16	1992-09-15	Analogifremgangsmåte for fremstilling av medisinsk virksomme 1-karboksyalkylkinoksalin-2,3 (1H,4H) -dionforbindelser og farmasöytisk godtagbare salter derav

Country Status (20)

Country	Link
US (1)	US5166155A (cs)
EP (1)	EP0520024B1 (cs)
JP (1)	JPH05505810A (cs)
AT (1)	ATE139530T1 (cs)
AU (1)	AU652560B2 (cs)
CA (1)	CA2078429A1 (cs)
CS (1)	CS68791A3 (cs)
DE (1)	DE69120400T2 (cs)
DK (2)	DK69790D0 (cs)
ES (1)	ES2089204T3 (cs)
FI (1)	FI924118A0 (cs)
GR (1)	GR3020560T3 (cs)
HU (1)	HUT62274A (cs)
IE (1)	IE910685A1 (cs)
IL (1)	IL97405A (cs)
NO (1)	NO179949C (cs)
NZ (1)	NZ237431A (cs)
PT (1)	PT97047B (cs)
WO (1)	WO1991013878A1 (cs)
ZA (1)	ZA911779B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6057304A (en)	1992-10-26	2000-05-02	Schering Aktiengesellschaft	Quinoxaline-phosphonic acid derivatives
PT101004B (pt) *	1991-10-26	1999-10-29	Schering Ag	Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
WO1994000124A1 (en) *	1992-06-22	1994-01-06	Eckard Weber	Glycine receptor antagonists and the use thereof
FR2696466B1 (fr) *	1992-10-02	1994-11-25	Rhone Poulenc Rorer Sa	Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.
DE4314592A1 (de) *	1993-04-28	1994-11-03	Schering Ag	Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
IL109397A0 (en) *	1993-04-28	1994-07-31	Schering Ag	Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US5631373A (en) *	1993-11-05	1997-05-20	State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon	Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) *	1993-11-24	1995-06-01	Basf Ag	Neue Chinoxaline und Arzneimittel daraus
JPH09510695A (ja) *	1994-01-03	1997-10-28	エイシア・ファーマシュウティカルズ，インコーポレイテッド	８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用
DE4428152A1 (de) *	1994-06-22	1996-01-04	Basf Ag	Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
DE4436852A1 (de) *	1994-10-14	1996-04-18	Basf Ag	Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
DE4439492A1 (de) *	1994-10-25	1996-05-02	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5559447A (en) *	1994-11-17	1996-09-24	Cypress Semiconductor	Output buffer with variable output impedance
DE19519979A1 (de) *	1995-05-24	1996-11-28	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19521058A1 (de) *	1995-06-09	1996-12-12	Basf Ag	Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19545251A1 (de) *	1995-11-24	1997-05-28	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
GB9604400D0 (en)	1996-03-01	1996-05-01	Pfizer Ltd	Compounds useful in therapy
DE19624808A1 (de)	1996-06-21	1998-01-02	Basf Ag	Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
CA2269807C (en) *	1996-10-24	2007-04-10	Novartis Ag	Substituted aminoalkanephosphonic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO179551C (no) *	1987-11-10	1996-10-30	Novo Nordisk As	Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK715888D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Quinoxalinforbindelser, deres fremstilling og anvendelse
DK716188D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Quinoxalinforbindelser, deres fremstilling og anvendelse

1990
- 1990-03-16 DK DK069790A patent/DK69790D0/da not_active Application Discontinuation
1991
- 1991-03-01 IE IE068591A patent/IE910685A1/en unknown
- 1991-03-04 IL IL9740591A patent/IL97405A/en not_active IP Right Cessation
- 1991-03-11 ZA ZA911779A patent/ZA911779B/xx unknown
- 1991-03-12 US US07/667,855 patent/US5166155A/en not_active Expired - Fee Related
- 1991-03-14 NZ NZ237431A patent/NZ237431A/xx unknown
- 1991-03-15 JP JP91506759A patent/JPH05505810A/ja active Pending
- 1991-03-15 AU AU75767/91A patent/AU652560B2/en not_active Ceased
- 1991-03-15 DK DK91906855.1T patent/DK0520024T3/da active
- 1991-03-15 WO PCT/DK1991/000078 patent/WO1991013878A1/en not_active Ceased
- 1991-03-15 DE DE69120400T patent/DE69120400T2/de not_active Expired - Fee Related
- 1991-03-15 AT AT91906855T patent/ATE139530T1/de not_active IP Right Cessation
- 1991-03-15 EP EP91906855A patent/EP0520024B1/en not_active Expired - Lifetime
- 1991-03-15 FI FI924118A patent/FI924118A0/fi not_active Application Discontinuation
- 1991-03-15 ES ES91906855T patent/ES2089204T3/es not_active Expired - Lifetime
- 1991-03-15 HU HU922953A patent/HUT62274A/hu unknown
- 1991-03-15 PT PT97047A patent/PT97047B/pt not_active IP Right Cessation
- 1991-03-15 CA CA002078429A patent/CA2078429A1/en not_active Abandoned
- 1991-03-15 CS CS91687A patent/CS68791A3/cs unknown
1992
- 1992-09-15 NO NO923586A patent/NO179949C/no unknown
1996
- 1996-07-17 GR GR960401929T patent/GR3020560T3/el unknown

Also Published As

Publication number	Publication date
AU652560B2 (en)	1994-09-01
ES2089204T3 (es)	1996-10-01
EP0520024A1 (en)	1992-12-30
ATE139530T1 (de)	1996-07-15
HU9202953D0 (en)	1992-12-28
IL97405A (en)	1995-12-08
AU7576791A (en)	1991-10-10
DK0520024T3 (da)	1996-10-14
PT97047B (pt)	1998-07-31
EP0520024B1 (en)	1996-06-19
FI924118A7 (fi)	1992-09-15
HUT62274A (en)	1993-04-28
DE69120400D1 (de)	1996-07-25
IL97405A0 (en)	1992-06-21
DK69790D0 (da)	1990-03-16
WO1991013878A1 (en)	1991-09-19
NO923586D0 (no)	1992-09-15
CS68791A3 (en)	1992-02-19
PT97047A (pt)	1991-10-31
NO179949B (no)	1996-10-07
CA2078429A1 (en)	1991-09-17
FI924118L (fi)	1992-09-15
FI924118A0 (fi)	1992-09-15
NZ237431A (en)	1993-09-27
US5166155A (en)	1992-11-24
NO923586L (no)	1992-09-15
ZA911779B (en)	1991-12-24
IE910685A1 (en)	1991-09-25
DE69120400T2 (de)	1996-12-19
GR3020560T3 (en)	1996-10-31
JPH05505810A (ja)	1993-08-26

Publication	Publication Date	Title
NZ237431A (en)	1993-09-27	1-carboxyalkylquinoxaline-2,3-dione derivatives and medicaments
LU88749I2 (fr)	1996-08-23	TACRINE et ses dérivés pharmaceutiquement acceptables (COGNEX)
MA26718A1 (fr)	2004-12-20	Derives de quinoleine-2-one a substituant heteroaryle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
NO933200L (no)	1994-03-10	Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
FI93117C (fi)	1995-02-27	Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
ATE201671T1 (de)	2001-06-15	Chinolon und acridinon derivate zur behandlung der harninkontinenz
ES2060303T3 (es)	1994-11-16	Derivados de piperidiloxiisoxazol y quinuclidiniloxiisoxazol, su preparacion y su uso terapeutico.
FI92320B (fi)	1994-07-15	Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi
TW350838B (en)	1999-01-21	Quinoline derivatives
DE3167155D1 (en)	1984-12-20	Aminopropanol derivatives, process for their preparation and their use as fungicides
DE69514532D1 (de)	2000-02-17	Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung
ES2094545T3 (es)	1997-01-16	Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
NO823125L (no)	1983-03-17	Fremgangsmaate for fremstilling av terapeutisk aktive 2-amino-naftalen-derivater
ATE138265T1 (de)	1996-06-15	Verwendung von pyrido-indol-derivaten bei der behandlung ischämischer störungen
EP0276805A3 (en)	1989-03-22	Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
ES473834A1 (es)	1979-05-01	Procedimiento de preparacion de nuevos compuestos indolicos.
EP0543307A3 (en)	1993-06-30	Nootropic agent
DK639889A (da)	1990-06-23	Quinoxalinforbindelser, deres fremstilling og anvendelse